MDL 63766
Latest Information Update: 30 Sep 2005
At a glance
- Originator Biosearch Italia
- Class Antibacterials; Antifungals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 30 Sep 2005 Vicuron Pharmaceuticals has since been acquired by and merged into Pfizer
- 04 Sep 1995 No-Development-Reported for Mycoses in Italy (Topical)